Zealand Pharma A/S logo
Zealand Pharma A/S ZEAL
$ 17.47 0.52%

Annual report 2021
added 12-23-2023

report update icon

Zealand Pharma A/S Financial Statements 2011-2024 | ZEAL

Annual Financial Statements Zealand Pharma A/S

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

855 M 1.08 B 1.29 B 441 M 465 M - - - - - -

Shares

43.2 M 33.8 M 33.8 M 30.7 M 27.9 M - - - - - -

Historical Prices

19.8 31.9 38.3 14.7 16.9 - - - - - -

Net Income

-1.02 B -847 M -572 M 581 M -272 M -154 M -114 M -65 M -184 M 36.4 M 13.4 M

Revenue

293 M 353 M 41.3 M 38 M 140 M 235 M 188 M 154 M 6.57 M 224 M 142 M

Cost of Revenue

- - - - - - - - - - -

Gross Profit

174 M 263 M 40.9 M -142 M 125 M 203 M 165 M 140 M 5.7 M 208 M 142 M

Operating Income

-1.05 B -792 M -588 M - - - - - - - -

Interest Expense

- - - - - - - - - - -

EBITDA

-1.05 B -792 M -588 M -653 M -242 M -110 M -75.1 M -67.6 M -180 M 37.7 M 12.9 M

Operating Expenses

- 1.09 B 629 M 516 M 372 M 319 M 247 M 214 M 191 M 175 M 133 M

General and Administrative Expenses

- 203 M 67.9 M 78 M 47.5 M 52.5 M 44.6 M 39.8 M 34.2 M 27.6 M 34.9 M

All numbers in DKK currency

Quarterly Income Statement Zealand Pharma A/S

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - - - 39.8 M - - - 33 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - - - - -229 M - - - -113 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - 56.5 M - - - 9.92 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - 34.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - 22.3 M - - - 9.69 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - -218 M - - - -130 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - - -218 M - - - -130 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in DKK currency